An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment.

Osselaer, Jean-Claude;Cazenave, J P;Lambermont, M.;Garraud, O.;Corash, L.;et.al.
(2008) Vox sanguinis — Vol. 94, n° 4, p. 315-323 (2008)

Files

11277.pdf
  • Restricted Access
  • Adobe PDF
  • 159.97 KB

Details

Authors
  • Osselaer, Jean-ClaudeUCLouvain
    Author
  • Cazenave, J P
    Author
  • Lambermont, M.
    Author
  • Garraud, O.
    Author
  • Defoin, LaurenceUCLouvain
    Author
  • Corash, L.
    Author
Show more
Abstract
BACKGROUND: An active haemovigilance programme was implemented to survey adverse events (AE) associated with transfusion of platelets photochemically treated with amotosalen and ultraviolet A (PCT-PLT). The results of 5106 transfusions have already been reported. Here we report the results of an additional 7437 PCT-PLT transfusions. METHODS: The focus of this ongoing haemovigilance programme is to document all AEs associated with PCT-PLT transfusion. Data collected for AEs include: time of event after starting transfusion, clinical descriptions, vital signs, results from radiographs and bacterial cultures, event severity (Grade 0-4) and causal relationship to PCT-PLT transfusion. RESULTS: One thousand four hundred patients (mean 60 years, range 1-96) received PCT-PLT transfusions. The majority of the patients (53.4%) had haematology-oncology diseases and required conventional chemotherapy (44.8%) or stem cell transplantation (8.6%). Sixty-eight PCT-PLT transfusions were associated with AE. Acute transfusion reactions (ATR), classified as an AE possibly related, probably related, or related to PCT-PLT transfusions were infrequent (n = 55, 55/7437 = 0.7%) and most were of Grade 1 severity. Thirty-nine patients (39/1400 = 2.8%) experienced one or more ATRs. The most frequently reported signs/symptoms were chills, fever, urticaria, dyspnoea, nausea and vomiting. Five AEs were considered severe (> or = Grade 2); however, no causal relationship to PCT-PLT transfusion was found. Repeated exposure to PCT-PLT did not increase the likelihood of an ATR. No cases of transfusion-related acute lung injury and no deaths due to PCT-PLT transfusions were reported. CONCLUSIONS: Routine transfusion of PCT-PLT is well-tolerated in a wide range of patients. ATRs related to PCT-PLT transfusion were infrequent and most were of mild severity.
Affiliations

Citations

Osselaer, J.-C., Cazenave, J. P., Lambermont, M., Garraud, O., Hidajat, M., Barbolla, L., Tardivel, R., Defoin, L., Waller, C., Mendel, I., Raidot, J. P., Kandel, G., De Meuter, R., Fabrigli, P., Dehenau, D., Arroyo, J. L., Padrón, F., Gouezec, H., Corral, M., et al. (2008). An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment. Vox sanguinis, 94(4), 315-323. https://doi.org/10.1111/j.1423-0410.2007.01035.x (Original work published 2008)